AzTrials
AzTrials

Postoperative RecoveryNCT06341049

Effect of Three Different Postcesarean Analgesic Techniques on QbsQor-10 Score

A study testing Intraperitoneal local anasthetic application + local anesthetic wound infiltration, Intrathecal morphine application and Quadratus lumborum block tip 1 application in people with Postoperative Recovery, run by Ataturk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the effects of three different postsesarean analgesia techniques, including instillation of local anesthetic into the peritoneum with infiltration into all layers of the anterior abdominal wall, intrathecal morphine injection with local anesthetic, and quadrotus lumborum type 1… Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Postoperative Recovery
What is being tested?
Intraperitoneal local anasthetic application + local anesthetic wound infiltration, Intrathecal morphine application and Quadratus lumborum block tip 1 application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteTurkey (Türkiye)
Study dates
12 Mar 2024to 15 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Elective cesarean section under spinal anesthesia
  • Full-term singleton pregnancy
  • Agree to participate in the study
  • American Society of Anaesthesiology Score of II

Who cannot join

  • Contrindication for neuraxial anesthesia
  • ASA≥3, diabetes, preeclampsia, cardiovascular disease, chronic pain and neuropathic pain
  • Age< 18 or > 50
  • Multiple pregnancy
  • Presence of psychiatric diseases
  • Gave a history of allergic to any medication in the study protocol
Show all 16Show fewer
  • Gave a history of chronic pain
  • Unable to consent
  • BMI>35 kg/m2
  • Those who were given opioids during the operation due to intraoperative pain
  • Those who have had previous abdominal surgery
  • Patients who failed spinal anesthesia and switched to general anesthesia
  • Those who have excessive bleeding or uterine atony during the operation
  • Does not understand VAS
  • Those who have a drain placed in the area to be infiltrated
  • Gave a history of drug addiction

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ataturk University

    Erzurum, Palandoken

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Three Different Postcesarean Analgesic Techniques on ObsQoR-10 Score: Prospective, Randomized Trial

The aim of this study is to evaluate the effects of three different postsesarean analgesia techniques, including instillation of local anesthetic into the peritoneum with infiltration into all layers of the anterior abdominal wall, intrathecal morphine injection with local anesthetic, and quadrotus lumborum type 1 block, on the postoperative recovery of women using the ObsQoR-10 score..

Read the detailed description

This study will be planned on women who will undergo elective cesarean section surgery with neuraxial anesthesia, after obtaining ethics committee approval and written informed consent from the patients.Parturients will be randomized by the statistician using a computerized random numbers table and divided into 3 equal groups: Group IPLA + LWI, Group QLB 1 and Group M.Postoperatively, patients' ObsQoR-10 scores will be evaluated and recorded at the 24th and 48th hours.

Being tested
Intraperitoneal local anasthetic application + local anesthetic wound infiltration, Intrathecal morphine application, Quadratus lumborum block tip 1 application

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intraperitoneal local anasthetic application + local anesthetic wound infiltrationProcedure or surgery

    For Group Intraperitoneal local anasthetic+ loal anesthetic wound infiltration, after the birth of the newborn and placenta, the uterus is taken out and closed, the blood accumulated in the pelvis is carefully wiped with surgical towels, and after complete hemostasis is achieved, sterilely prepared 20 ml 0.5% bupivacaine + 20 ml 2% lidocaine +1 A total of 40 ml of solution containing 200,000 epinephrine will be given to the surgeon. 10 ml of this solution will be instilled into all four quadrants of the uterus before closing the parietal peritoneum or fascia. The parietal peritoneal layer will be sutured or left open, depending on the surgeon's preference. 10 ml will be infiltrated around the edges of the rectus aponeurosis, and the remaining 20 ml will be infiltrated subcutaneously into the wound area.

  • Intrathecal morphine applicationProcedure or surgery

    Group Morphine will be given 11.2 mg hyperbaric bupivacaine + 15 µg fentanyl + 150 µg morphine into the spinal space.

  • Quadratus lumborum block tip 1 applicationProcedure or surgery

    In Group Quadratus lumborum block, Quadratus lumborum block type I, a total of 40 ml of a solution containing 20 ml of 0.5% bupivacaine + 20 ml of 2% lidocaine + 1:200,000 epinephrine will be applied bilaterally under ultrasound guidance.

Study groups in NCT06341049
Study groupRoleWhat they receive
Group Intraperitoneal local anasthetic+ loal anesthetic wound infiltrationActive comparatorFor Group Intraperitoneal local anasthetic+ loal anesthetic wound infiltration, after the birth of the newborn and placenta, the uterus is taken out and closed, the blood accumulated in the pelvis is carefully wiped with surgical towels, and after complete hemostasis is achieved, sterilely prepared 20 ml 0.5% bupivacaine + 20 ml 2% lidocaine +1 A total of 40 ml of solution containing 200,000 epinephrine will be given to the surgeon. 10 ml of this solution will be instilled into all four quadrants of the uterus before closing the parietal peritoneum or fascia. The parietal peritoneal layer will be sutured or left open, depending on the surgeon's preference. 10 ml will be infiltrated around the edges of the rectus aponeurosis, and the remaining 20 ml will be infiltrated subcutaneously into the wound area.
Receives: Procedure: Intraperitoneal local anasthetic application + local anesthetic wound infiltration
Group MorphineActive comparatorGroup Morphine will be given 11.2 mg hyperbaric bupivacaine + 15 µg fentanyl + 150 µg morphine into the spinal space.
Receives: Procedure: Intrathecal morphine application
Group Quadratus lumborum blockActive comparatorIn Group Quadratus lumborum block, Quadratus lumborum block type I, a total of 40 ml of a solution containing 20 ml of 0.5% bupivacaine + 20 ml of 2% lidocaine + 1:200,000 epinephrine will be applied bilaterally under ultrasound guidance.
Receives: Procedure: Quadratus lumborum block tip 1 application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. obstetric quality of recovery-10 (ObsQoR-10) scores of parturient at the 24th and 48th postoperative hours

    For post-cesarean analgesia, patients will receive instillation of local anesthetic into the peritoneum with infiltration into all layers of the anterior abdominal wall, intrathecal morphine injection with local anesthetic, and quadrotus lumborum type 1 block. ObsQoR-10 scores of the patients will be evaluated at the 24th and 48th hours postoperatively.

    Measured: Postoperative 24th and 48th hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2024
  2. Study start12 Mar 2024
  3. Primary completion2 May 2025
  4. Study completion15 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06341049
Sponsor's protocol ID
2024-03/14
Status last verified
Nov 2025
First submitted
19 Mar 2024
Last updated
17 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intraperitoneal local anasthetic application + local anesthetic wound infiltration, Intrathecal morphine application and Quadratus lumborum block tip 1 application in people with Postoperative Recovery, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

obstetric quality of recovery-10 (ObsQoR-10) scores of parturient at the 24th and 48th postoperative hours (time frame: Postoperative 24th and 48th hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in